Do patients with liver cancer require antiviral therapy?

May 12, 2021 Source: Cainiu Health
Dr. Liu Dahai
Introduction
Patients with hepatitis B are at high risk for hepatocellular carcinoma (HCC). Current research has confirmed that antiviral therapy can delay HCC progression and recurrence. Therefore, lifelong antiviral treatment is a critically important therapeutic strategy for HCC patients. Several antiviral agents are commonly used, including entecavir, adefovir dipivoxil, and interferon; however, the specific choice of medication must be determined according to physician guidance.

Clinically, many patients with hepatocellular carcinoma (HCC) progress sequentially from chronic hepatitis to cirrhosis and ultimately to HCC. Therefore, identifying the underlying etiology is essential in managing HCC patients. So, do HCC patients require antiviral therapy? Below, we provide a detailed explanation.

2 (3)_副本.jpg

Do HCC Patients Require Antiviral Therapy?

Patients with hepatitis B virus (HBV) infection constitute a high-risk group for developing HCC. Current evidence confirms that antiviral therapy can delay HCC progression and reduce recurrence rates. Consequently, lifelong antiviral treatment represents a critical therapeutic strategy for HCC patients. Several antiviral agents are available—including entecavir, adefovir dipivoxil, and interferon—though specific drug selection must be guided by physician recommendation. Failure to initiate antiviral therapy during HCC treatment may substantially diminish overall therapeutic efficacy. Thus, concurrent management of the underlying viral hepatitis is paramount. For postoperative HCC patients, antiviral therapy not only lowers the risk of viral reactivation but also suppresses viral replication, attenuates hepatic inflammatory responses, and significantly reduces the likelihood of malignant transformation in residual healthy hepatocytes—thereby decreasing postoperative recurrence risk.

9_副本1.jpg

Knowledge Expansion: Preventing Hepatocellular Carcinoma

1. Regular Health Screening

Many chronic liver diseases—such as chronic HBV infection, cirrhosis, and alcoholic liver disease—may gradually progress to HCC over time. Individuals at high risk for HCC should undergo routine surveillance. Early screening and monitoring enable timely detection and intervention for early-stage HCC.

2. Smoking Cessation and Alcohol Abstinence

Cigarette smoke contains numerous toxic chemicals, particularly nicotine, which poses serious health hazards. Chronic alcohol consumption inflicts substantial damage on the liver; long-term heavy drinking especially exacerbates hepatic burden and impairs detoxification function. Prolonged exposure to such insults predisposes individuals to liver disease, which—if left untreated—may advance to HCC.

3 (2)_副本.jpg

The above outlines whether antiviral therapy is indicated for HCC patients. We hope this information proves helpful.